1
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Louis DN, Perry A, Burger P, Ellison DW,
Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP,
Eberhart C, et al: International society of neuropathology-haarlem
consensus guidelines for nervous system tumor classification and
grading. Brain Pathol. 24:429–435. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Cruceru ML, Neagu M, Demoulin JB and
Constantinescu SN: Therapy targets in glioblastoma and cancer stem
cells: Lessons from hematopoietic neoplasms. J Cell Mol Med.
17:1218–1235. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bryukhovetskiy I, Bryukhovetsky A,
Khotimchenko Y, Mischenko P, Tolok E and Khotimchenko R:
Combination of the multipotent mesenchymal stromal cell
transplantation with administration of temozolomide increases
survival of rats with experimental glioblastoma. Mol Med Rep.
12:2828–2834. 2015.PubMed/NCBI
|
6
|
Bryukhovetskiy A, Shevchenko V, Kovalev S,
Chekhonin V, Baklaushev V, Bryukhovetskiy I and Zhukova M: To the
novel paradigm of proteome-based cell therapy of tumors: Through
comparative proteome mapping of tumor stem cells and
tissue-specific stem cells of humans. Cell Transplant. 23(Suppl 1):
S151–S170. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Saraceni F, Shem-Tov N, Olivieri A and
Nagler A: Mobilized peripheral blood grafts include more than
hematopoietic stem cells: The immunological perspective. Bone
Marrow Transplant. 50:886–891. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Syme R, Bajwa R, Robertson L, Stewart D
and Glück S: Comparison of CD34 and monocyte-derived dendritic
cells from mobilized peripheral blood from cancer patients. Stem
Cells. 23:74–81. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Moore XL, Lu J, Sun L, Zhu CJ, Tan P and
Wong MC: Endothelial progenitor cells ‘homing’ specificity to brain
tumors. Gene Ther. 11:811–818. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen
L, Xiao HL, Wang B, Yi L, Wang QL, et al: Tumor-associated
microglia/macrophages enhance the invasion of glioma stem-like
cells via TGF-β1 signaling pathway. J Immunol. 189:444–453. 2012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
da Fonseca AC and Badie B: Microglia and
macrophages in malignant gliomas: Recent discoveries and
implications for promising therapies. Clin Dev Immunol.
2013:2641242013.PubMed/NCBI
|
12
|
Barth RF and Kaur B: Rat brain tumor
models in experimental neuro-oncology: The C6, 9L, T9, RG2, F98,
BT4C, RT-2 and CNS-1 gliomas. J Neurooncol. 94:299–312. 2009.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Paxinos G and Watson C: The Rat Brain in
Stereotaxic Coordinates (6th). Elsevier Academic Press. San Diego:
2007.
|
14
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Trautmann F, Cojoc M, Kurth I, Melin N,
Bouchez LC, Dubrovska A and Peitzsch C: CXCR4 as biomarker for
radioresistant cancer stem cells. Int J Radiat Biol. 90:687–699.
2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhao D, Najbauer J, Garcia E, Metz MZ,
Gutova M, Glackin CA, Kim SU and Aboody KS: Neural stem cell
tropism to glioma: Critical role of tumor hypoxia. Mol Cancer Res.
6:1819–1829. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wierenga AT, Vellenga E and Schuringa JJ:
Convergence of hypoxia and TGFβ pathways on cell cycle regulation
in human hematopoietic stem/progenitor cells. PLoS One.
9:e934942014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Held-Feindt J, Hattermann K, Müerköster
SS, Wedderkopp H, Knerlich-Lukoschus F, Ungefroren H, Mehdorn HM
and Mentlein R: CX3CR1 promotes recruitment of human
glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res.
316:1553–1566. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Coniglio SJ, Eugenin E, Dobrenis K,
Stanley ER, West BL, Symons MH and Segall JE: Microglial
stimulation of glioblastoma invasion involves epidermal growth
factor receptor (EGFR) and colony stimulating factor 1 receptor
(CSF-1R) signaling. Mol Med. 18:519–527. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Greenbaum A, Hsu YM, Day RB, Schuettpelz
LG, Christopher MJ, Borgerding JN, Nagasawa T and Link DC: CXCL12
in early mesenchymal progenitors is required for haematopoietic
stem-cell maintenance. Nature. 495:227–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Desbaillets I, Tada M, de Tribolet N,
Diserens AC, Hamou MF and Van Meir EG: Human astrocytomas and
glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in
vivo and in vitro. Int J Cancer. 58:240–247. 1994. View Article : Google Scholar : PubMed/NCBI
|
22
|
Markovic DS, Vinnakota K, Chirasani S,
Synowitz M, Raguet H, Stock K, Sliwa M, Lehmann S, Kälin R, van
Rooijen N, et al: Gliomas induce and exploit microglial MT1-MMP
expression for tumor expansion. Proc Natl Acad Sci USA.
106:12530–12535. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wu A, Wei J, Kong LY, Wang Y, Priebe W,
Qiao W, Sawaya R and Heimberger AB: Glioma cancer stem cells induce
immunosuppressive macrophages/microglia. Neuro Oncol. 12:1113–1125.
2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hu Y, Xue J, Yang Y, Zhou X, Qin C, Zheng
M, Zhu H, Liu Y, Liu W, Lou G, et al: Lipocalin 2 upregulation
protects hepatocytes from IL1-β-induced stress. Cell Physiol
Biochem. 36:753–762. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ikushima H, Todo T, Ino Y, Takahashi M,
Miyazawa K and Miyazono K: Autocrine TGF-beta signaling maintains
tumorigenicity of glioma-initiating cells through Sry-related
HMG-box factors. Cell Stem Cell. 5:504–514. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Caja L, Bellomo C and Moustakas A:
Transforming growth factor β and bone morphogenetic protein actions
in brain tumors. FEBS Lett. 589:1588–1597. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao
RC, Ye L and Zhang X: Suppression of tumorigenesis by human
mesenchymal stem cells in a hepatoma model. Cell Res. 18:500–507.
2008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Moreno E: Cancer: Darwinian tumour
suppression. Nature. 509:435–436. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Cousin B, Ravet E, Poglio S, De Toni F,
Bertuzzi M, Lulka H, Touil I, André M, Grolleau JL, Péron JM, et
al: Adult stromal cells derived from human adipose tissue provoke
pancreatic cancer cell death both in vitro and in vivo. PLoS One.
4:e62782009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang Y, Ren X, Shi M, Jiang Z, Wang H, Su
Q, Liu Q, Li G and Jiang G: Downregulation of STAT3 and activation
of MAPK are involved in the induction of apoptosis by HNK in
glioblastoma cell line U87. Oncol Rep. 32:2038–2046.
2014.PubMed/NCBI
|
31
|
Sun JS, Yang YJ, Zhang YZ, Huang W, Li ZS
and Zhang Y: Minocycline attenuates pain by inhibiting spinal
microglia activation in diabetic rats. Mol Med Rep. 12:2677–2682.
2015.PubMed/NCBI
|
32
|
Färber K, Synowitz M, Zahn G, Vossmeyer D,
Stragies R, van Rooijen N and Kettenmann H: An alpha5beta1 integrin
inhibitor attenuates glioma growth. Mol Cell Neurosci. 39:579–585.
2008. View Article : Google Scholar : PubMed/NCBI
|